EVLV — what changed in the latest 10-Q
A section-by-section comparison of EVLV's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-11 vs the prior 10-Q · 2026-05-12
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +67 | −46 | ~35 | 55 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | +1 | −1 | ~6 | 24 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | +33 | −32 | ~36 | 216 |
| Other information | Text added/removed | 0 | 0 | ~1 | 2 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-11
Non-recurring employee restructuring and other separation costs— 833 — 2,970
Other non-recurring legal and regulatory costs903 5,979 804 9,540
For the three months ended June 30, 2026, Adjusted EBITDA was $4.4 million, compared to $2.1 million for the three months ended June 30, 2025, representing an improvement of $2.3 million year-over‑year. This improvement was primarily driven by revenue growth, increased operating leverage, and contin…
efficiency and commercial terms. The Company continues to monitor cash flows and capital requirements associated with the transition to ensure sufficient resources are available to support ongoing operations and strategic initiatives.
The following table summarizes our results of operations for the three months ended June 30, 2026 and 2025 (in thousands):
Text removed vs the prior filing · source: 10-Q · 2026-05-12
Change in fair value of public warrant liability(2,044)(1,721)
Non-recurring employee restructuring and other separation costs— 2,137
For the three months ended March 31, 2026, Adjusted EBITDA was $3.9 million, compared to $2.1 million for the three months ended March 31, 2025, representing an improvement of $1.9 million year-over‑year. This improvement was primarily driven by revenue growth, increased operating leverage, and cont…
Comparison of the Three Months Ended March 31, 2026 and 2025
The following table summarizes our results of operations for the three months ended March 31, 2026 and 2025 (in thousands):
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-11
however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying …
Text removed vs the prior filing · source: 10-Q · 2026-05-12
not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-11
•Changes in the fair value of our contingently returnable founder shares and efforts to enforce the return and cancellation of forfeited founder shares could materially affect our financial results.
We have a history of losses. We have incurred net losses of $14.3 million and $42.2 million for the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, we had an accumulated deficit of $402.1 million. Our ability to forecast our future operating results is subject to a number…
manufacturers. While we anticipate reduced product costs and improved gross margin over time, such results may not materialize. Onboarding a new supplier involves various inherent risks that could adversely affect our production capacity and product quality, and negatively impact revenue, gross prof…
We recognize a substantial portion of our revenue ratably over the terms of our agreements with customers, which generally occurs over a four-year period. As a result, a substantial portion of the revenue that we report in each period will be derived from the recognition of deferred revenue relating…
Consequently, a decline in new sales or renewals in any one period may not be immediately reflected in our revenue results for that period. This decline, however, would negatively affect our revenue in future periods. Accordingly, the effect of significant downturns in sales and market acceptance of…
Text removed vs the prior filing · source: 10-Q · 2026-05-12
•Certain of our warrants, earn-out shares, and founder shares are accounted for as liabilities and the changes in value of such securities could have a material effect on our financial results.
We have a history of losses. We have incurred net losses of $5.9 million and $1.7 million for the three months ended March 31, 2026 and 2025, respectively. As of March 31, 2026, we had an accumulated deficit of $393.7 million. Our
ability to forecast our future operating results is subject to a number of uncertainties, including our ability to plan for and model future growth. We have encountered and will continue to encounter risks and uncertainties frequently experienced by growing companies in rapidly evolving industries. …
renewal date. It cannot be certain that we will retain these reseller partners or that we will be able to secure additional or replacement reseller partners. The loss of one or more of our significant reseller partners or a decline in the number or size of orders from them could harm our operating r…
We recognize a substantial portion of our revenue ratably over the terms of our agreements with customers, which generally occurs over a four-year period. As a result, a substantial portion of the revenue that we report in each period will be derived from the recognition of deferred revenue relating…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice